openPR Logo
Press release

Psoriatic Arthritis Treatment Market to Soar 7.8% Annually, Reaching USD25.3 Billion by 2034 Amidst Aging Population and Biologics Innovation

07-28-2025 08:26 AM CET | Health & Medicine

Press release from: Future Market Insights Inc

Psoriatic Arthritis (PsA) Treatment Market

Psoriatic Arthritis (PsA) Treatment Market

The global Psoriatic Arthritis (PsA) Treatment Market is projected for substantial growth, with an estimated value of USD 11,973.7 million in 2024, set to reach USD 25,375.6 million by 2034. This expansion reflects a robust Compound Annual Growth Rate (CAGR) of 7.8% over the forecast period, driven by the increasing prevalence of psoriasis and a rapidly expanding patient pool.

Click Here for More Information:- https://www.futuremarketinsights.com/reports/psoriatic-arthritis-psa-treatment-market

Rising Incidence and Aging Demographics Fuel Demand

The need for psoriatic arthritis treatment is directly linked to the significant number of people affected by psoriasis globally, estimated at approximately 125 million. As this number climbs, so does the demand for related treatments. Psoriasis predominantly affects individuals in the 50-60 age range, and with the world's population aging rapidly, more individuals with psoriatic arthritis are seeking medical attention. Furthermore, symptoms like morning stiffness, nail pitting, and flaky scalp drive patients to seek prompt treatment, accelerating market progression.

Digitalization Enhances Treatment Accessibility

The industry is embracing the digital age, with online consulting and treatment options facilitating easier access to medicine. The widespread availability of treatment through digital platforms is leading to a faster rate of demand establishment, modernizing the market and improving patient convenience.

Challenges: High Costs and Side Effects

Despite the positive outlook, the industry faces challenges. The high cost of specific treatments can deter patients. Additionally, potential side effects of medications for psoriatic arthritis, which may include infection, lung inflammation, and hair loss, also present a negative aspect that the market must address.

Diverse Treatment Options and Clinical Trials Drive Innovation

The wide variety of available treatment options significantly boosts the industry, ranging from over-the-counter drugs to extensive surgeries, including biologics, steroid injections, and joint replacement surgeries. Regulatory bodies like the Food and Drug Administration (FDA) are rapidly approving new treatments, such as Guselkumab and Risankizumab-rzaa, further aiding the sector's ascent. The industry remains dynamic due to continuous clinical trials, with pharmaceutical companies heavily investing in research to refine treatments and promising drugs currently under trial.

Get Sample Report: - https://www.futuremarketinsights.com/reports/sample/rep-gb-2718

Biologics and Injectables Lead Segmental Growth

Biologics are poised to be the leading drug type, projected to account for 57.2% of the market share in 2024. While traditional DMARDs like methotrexate have been common, biological versions are gaining prominence due to their effectiveness in combating inflammation with fewer reported side effects. Regulatory approvals for biologics such as adalimumab (Humira) and ixekizumab (Taltz) further solidify their leadership. In terms of administration, injectable drugs are predicted to remain dominant, holding an 84.9% share in 2024, due to their reputation for faster therapeutic action.

Key Regional Growth Drivers

The United States is set to witness significant industry progress at a CAGR of 7.5%, driven by its rapidly aging population. India is anticipated to be a highly lucrative market, expanding at a CAGR of 8.9%, supported by national health schemes promoting psoriasis awareness. The United Kingdom is expected to see market growth at a CAGR of 7.6%, fueled by the development and approval of new drugs.

Competitive Landscape and Strategic Collaborations

The psoriatic arthritis treatment market is characterized by intense competition, with key players prioritizing new drug development. Companies like Pfizer Inc. and Johnson & Johnson are investing in trials and actively seeking partnerships to develop novel drug options. Collaborative strategies also extend to working with public bodies to raise disease awareness. Recent developments include Wellmin Health's launch of the Pathway platform in September 2023 and Biocon Biologics' agreement with Janssen Biotech Inc. in February 2024 to commercialize Bmab 1200, underscoring a dynamic market focused on innovation and patient support.

Discover Related Research:-

Atherosclerosis Market
https://www.futuremarketinsights.com/reports/atherosclerosis-market

Mucopolysaccharidosis Treatment Market
https://www.futuremarketinsights.com/reports/mucopolysaccharidosis-treatment-market

Direct Oral Anticoagulants Market
https://www.futuremarketinsights.com/reports/direct-oral-anticoagulants-market

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analystsworldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Psoriatic Arthritis Treatment Market to Soar 7.8% Annually, Reaching USD25.3 Billion by 2034 Amidst Aging Population and Biologics Innovation here

News-ID: 4121844 • Views:

More Releases from Future Market Insights Inc

Oatmeal Market Soars, Forecast to Reach USD 11129.4 Million by 2035 Amid Health and Convenience Revolution
Oatmeal Market Soars, Forecast to Reach USD 11129.4 Million by 2035 Amid Health …
The global oatmeal market, valued at USD 6,378.3 million in 2025, is poised for remarkable growth, with a new market outlook forecasting it to reach USD 11,129.4 million by 2035. Driven by a robust Compound Annual Growth Rate (CAGR) of 5.7%, this expansion is fueled by a powerful convergence of consumer trends, including a heightened focus on health, the demand for convenience, and a shift toward sustainable and plant-based diets. The
Native Starch Market to Reach USD 2.9 Billion by 2035, Driven by Clean-Label and Natural Food Demand
Native Starch Market to Reach USD 2.9 Billion by 2035, Driven by Clean-Label and …
The global native starch market is on a robust growth trajectory, propelled by the worldwide movement toward clean-label and minimally processed ingredients. Valued at USD 1.8 billion in 2025, the market is forecasted to expand to USD 2.9 billion by 2035, with a healthy Compound Annual Growth Rate (CAGR) of 5.7%. This significant growth underscores native starch's critical role in meeting evolving consumer demands for healthier, more natural food and
Microbial Seed Treatment Market to Grow at 12.8% CAGR, Reaching USD 4.47 Billion by 2035 with Sustainable Farming Boost
Microbial Seed Treatment Market to Grow at 12.8% CAGR, Reaching USD 4.47 Billion …
The global microbial seed treatment market is poised for significant growth, with a new market outlook forecasting a robust compound annual growth rate (CAGR) of 12.8% from 2025 to 2035. Valued at an estimated USD 1.34 billion in 2025, the market is projected to reach an impressive USD 4.47 billion by 2035, reflecting a dramatic shift towards eco-friendly and high-performance agricultural solutions. This surge is fueled by a combination of
Potash Ores Market to Reach USD 2.3 Billion by 2035, Driven by Agricultural Demand and Sustainable Practices
Potash Ores Market to Reach USD 2.3 Billion by 2035, Driven by Agricultural Dema …
The global potash ores market, a vital component of the agricultural and industrial sectors, is set for robust expansion, with its value projected to grow from an estimated USD 1.6 billion in 2025 to USD 2.3 billion by 2035. This represents a steady Compound Annual Growth Rate (CAGR) of 3.5%, according to a new market analysis. The consistent growth is primarily fueled by the accelerating global demand for food, which

All 5 Releases


More Releases for Treatment

Trigeminal Neuralgia Treatment Market Size, Trigeminal Neuralgia Treatment Marke …
Trigeminal Neuralgia Treatment Market Dynamics are clarified by an in-depth review of facts on current and emerging trends. To understand a resource, the paper uses Porter's five forces to examine the importance of numerous qualities such as understanding of suppliers and customers, dangers provided by various agents, competitive strength, and promising new businesses. precious. Furthermore, the study covers numerous firms' Trigeminal Neuralgia Treatment research data, benefit, gross margin, worldwide market
Medical Tourism Market Report by Treatment Type (Dental Treatment, Cosmetic Trea …
The global medical tourism market accounted for $104.68 billion in 2019, and is projected to reach $273.72 billion by 2027, registering a CAGR of 12.8% from 2019 to 2027 in terms of value. View Full Report: https://reports.valuates.com/market-reports/ALLI-Auto-0P310/medical-tourism In terms of volume, the global medical tourism market accounted for 23,042.90 thousand patients in 2019, and is projected to reach 70,358.61 thousand patients by 2027, registering a CAGR of 15.0% from 2019 to
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products. Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products. Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,
Medical Tourism Market by Treatment Type (Dental Treatment, Cosmetic Treatment, …
Medical Tourism Market Overview: The global medical tourism market was valued at $53,768 million in 2017, and is estimated to reach at $143,461 million by 2025, registering a CAGR of 12.9% from 2018 to 2025. Organized travel across international borders to avail medical treatment of some form, which may or may not be available in the travelers home country is defined as medical tourism. Medical tourists travel abroad for the maintenance, enhancement,
Substance Use Disorder Treatment Market By Type (Alcohol abuse treatment, Nicoti …
According to World Health Organization (WHO), the leading cause of disability around the world is not a physical disease, but a serious mood disorder known as depression. Around 350 million people suffer from depression worldwide, and that only about 50% of these individuals will ever receive treatment. According to Anxiety and Depression Association of America, in the U.S., over 15 million adults experience an episode of clinical depression in any